RELATION OF PLASMA D-DIMER CONCENTRATIONS TO CORONARY-ARTERY REPERFUSION BEFORE AND AFTER THROMBOLYTIC TREATMENT IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

被引:22
作者
BRENNER, B [1 ]
FRANCIS, CW [1 ]
FITZPATRICK, PG [1 ]
ROTHBARD, RL [1 ]
COX, C [1 ]
HACKWORTHY, RA [1 ]
ANDERSON, JL [1 ]
SORENSEN, SG [1 ]
MARDER, VJ [1 ]
机构
[1] UNIV ROCHESTER,MED CTR,SCH MED,DEPT MED,HEMATOL UNIT,POB 610,601 ELMWOOD AVE,ROCHESTER,NY 14642
关键词
D O I
10.1016/0002-9149(89)90175-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1179 / 1184
页数:6
相关论文
共 27 条
[1]   FORMATION OF SOLUBLE FIBRIN OLIGOMERS IN PURIFIED SYSTEMS AND IN PLASMA [J].
ALKJAERSIG, N ;
FLETCHER, AP .
BIOCHEMICAL JOURNAL, 1983, 213 (01) :75-83
[2]   MULTICENTER REPERFUSION TRIAL OF INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX (APSAC) IN ACUTE MYOCARDIAL-INFARCTION - CONTROLLED COMPARISON WITH INTRACORONARY STREPTOKINASE [J].
ANDERSON, JL ;
ROTHBARD, RL ;
HACKWORTHY, RA ;
SORENSEN, SG ;
FITZPATRICK, PG ;
DAHL, CF ;
HAGAN, AD ;
BROWNE, KF ;
SYMKOVIAK, GP ;
MENLOVE, RL ;
BARRY, WH ;
ECKERSON, HW ;
MARDER, VJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 11 (06) :1153-1163
[3]  
ANSINGER RW, 1981, NEW ENGL J MED, V305, P297
[4]   THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE [J].
CHESEBRO, JH ;
KNATTERUD, G ;
ROBERTS, R ;
BORER, J ;
COHEN, LS ;
DALEN, J ;
DODGE, HT ;
FRANCIS, CK ;
HILLIS, D ;
LUDBROOK, P ;
MARKIS, JE ;
MUELLER, H ;
PASSAMANI, ER ;
POWERS, ER ;
RAO, AK ;
ROBERTSON, T ;
ROSS, A ;
RYAN, TJ ;
SOBEL, BE ;
WILLERSON, J ;
WILLIAMS, DO ;
ZARET, BL ;
BRAUNWALD, E .
CIRCULATION, 1987, 76 (01) :142-154
[5]   PREVALENCE OF TOTAL CORONARY-OCCLUSION DURING THE EARLY HOURS OF TRANSMURAL MYOCARDIAL-INFARCTION [J].
DEWOOD, MA ;
SPORES, J ;
NOTSKE, R ;
MOUSER, LT ;
BURROUGHS, R ;
GOLDEN, MS ;
LANG, HT .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (16) :897-902
[6]   RELATIONSHIP BETWEEN ELEVATED PLASMA-LEVELS OF CROSS-LINKED FIBRIN DEGRADATION PRODUCTS (XL-FDP) AND THE CLINICAL PRESENTATION OF PATIENTS WITH MYOCARDIAL-INFARCTION [J].
EISENBERG, PR ;
SHERMAN, LA ;
PEREZ, J ;
JAFFE, AS .
THROMBOSIS RESEARCH, 1987, 46 (01) :109-120
[7]   FIBRINOPEPTIDE-A - A MARKER OF ACUTE CORONARY THROMBOSIS [J].
EISENBERG, PR ;
SHERMAN, LA ;
SCHECTMAN, K ;
PEREZ, J ;
SOBEL, BE ;
JAFFE, AS .
CIRCULATION, 1985, 71 (05) :912-918
[8]   INCREASED IMMUNOREACTIVITY OF PLASMA AFTER FIBRINOLYTIC ACTIVATION IN AN ANTI-DD ELISA SYSTEM - ROLE OF SOLUBLE CROSSLINKED FIBRIN POLYMERS [J].
FRANCIS, CW ;
DOUGHNEY, K ;
BRENNER, B ;
KLINGBIEL, K ;
MARDER, VJ .
CIRCULATION, 1989, 79 (03) :666-673
[9]   ASSESSMENT OF FIBRIN DEGRADATION PRODUCTS DURING FIBRINOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION [J].
FRANCIS, CW ;
CONNAGHAN, DG ;
MARDER, VJ .
CIRCULATION, 1986, 74 (05) :1027-1036
[10]   INCREASED PLASMA-CONCENTRATION OF CROSS-LINKED FIBRIN POLYMERS IN ACUTE MYOCARDIAL-INFARCTION [J].
FRANCIS, CW ;
CONNAGHAN, DG ;
SCOTT, WL ;
MARDER, VJ .
CIRCULATION, 1987, 75 (06) :1170-1177